Outcomes of Device Closure of Atrial Septal Defects

Several devices have been designed and tried over the years to percutaneously close atrial septal defects (ASDs). Most of the devices were first experimented in animal models with subsequent clinical testing in human subjects. Some devices were discontinued or withdrawn from further clinical use for...

Full description

Bibliographic Details
Published in:Children
Main Author: P. Syamasundar Rao
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Subjects:
atrial septal defect
percutaneous closure
outcome
transcatheter occlusion
King and Mill’s Device
Rashkind’s devices
Online Access:https://www.mdpi.com/2227-9067/7/9/111
Description
Summary:Several devices have been designed and tried over the years to percutaneously close atrial septal defects (ASDs). Most of the devices were first experimented in animal models with subsequent clinical testing in human subjects. Some devices were discontinued or withdrawn from further clinical use for varied reasons and other devices received Food and Drug Administration (FDA) approval with consequent continued usage. The outcomes of both discontinued and currently used devices was presented in some detail. The results of device implantation are generally good when appropriate care and precautions are undertaken. At this time, Amplatzer Septal Occluder is most frequently utilized device for occlusion of secundum ASD around the world.
ISSN:2227-9067

Similar Items